Paul Dorian
Researcher Next ID · RN-032979
Researcher · Medicine
Toronto, Canada
- Works count
- 862
- Citation count
- 37,220
- H-index
- 96
- i10-index
- 384
Research interests
Publications
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
Canadian Journal of Cardiology · 2020 · https://doi.org/10.1016/j.cjca.2020.09.001
Prevention of Arrhythmia Device Infection Trial
Journal of the American College of Cardiology · 2018 · https://doi.org/10.1016/j.jacc.2018.09.068
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Canadian Journal of Cardiology · 2018 · https://doi.org/10.1016/j.cjca.2018.08.026
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Canadian Journal of Cardiology · 2016 · https://doi.org/10.1016/j.cjca.2016.07.591
Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke
Stroke · 2015 · https://doi.org/10.1161/strokeaha.115.008714
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Canadian Journal of Cardiology · 2014 · https://doi.org/10.1016/j.cjca.2014.08.001
Atrial Fibrillation in Patients with Cryptogenic Stroke
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1311376
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
Blood · 2014 · https://doi.org/10.1182/blood-2014-08-595496
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
Canadian Journal of Cardiology · 2012 · https://doi.org/10.1016/j.cjca.2012.01.021
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60986-6
Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation
Circulation Arrhythmia and Electrophysiology · 2010 · https://doi.org/10.1161/circep.110.958033
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0708789
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease
JAMA · 2007 · https://doi.org/10.1001/jama.297.4.367
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa041489
Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation
New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa013029
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy
Journal of the American College of Cardiology · 2000 · https://doi.org/10.1016/s0735-1097(00)00886-x
Amiodarone to Prevent Recurrence of Atrial Fibrillation
New England Journal of Medicine · 2000 · https://doi.org/10.1056/nejm200003303421302
Canadian Implantable Defibrillator Study (CIDS)
Circulation · 2000 · https://doi.org/10.1161/01.cir.101.11.1297
Current projects
No projects listed.